Chronic Obstructive Pulmonary Disease: Use of the St George’s Respiratory Questionnaire as a PRO Assessment Tool Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 26, 2018
May 4, 2020
4027ee92-8cfb-4ad2-8e77-14364c6dafdb
Related Documents
Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry
Guidance DocumentSeptember 6, 2018Center for Drug Evaluation and Research
Nonallergic Rhinitis: Developing Drug Products for Treatment
Guidance DocumentSeptember 6, 2018Center for Drug Evaluation and Research
Migraine: Developing Drugs for Acute Treatment
Guidance DocumentFebruary 16, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.